title: Retroperitoneal fibrosis after chemotherapy.
abstract: We report the case of a patient with a non-Hodgkin lymphoma, who after a standard chemotherapy protocol, developed retroperitoneal fibrosis (RPF) in the absence of radiotherapy or other known causes. The final diagnosis was reached with the microscopic examination of tissue obtained by fine-needle aspiration and true-cut biopsy of the retroperitoneal mass. RPF can be related to chemotherapy alone.
authors.affiliation: Department of Pathology, Medical School, University of Padova, Padova, Italy. ambrogio.fassina@unipd.it
authors.forename: Ambrogio
authors.initials: A
authors.lastname: Fassina
authors.forename: Rafael
authors.initials: R
authors.lastname: Boscolo Berto
authors.forename: Rafi
authors.initials: R
authors.lastname: El Mazloum
authors.forename: Fedra
authors.initials: F
authors.lastname: Gottardo
authors.forename: Walter
authors.initials: W
authors.lastname: Artibani
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001761:Bleomycin / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D003561:Cytarabine / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D005047:Etoposide / Q000009:adverse effects; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008727:Methotrexate / Q000009:adverse effects; D011241:Prednisone / Q000009:adverse effects; D012185:Retroperitoneal Fibrosis / Q000139:chemically induced*; D012186:Retroperitoneal Neoplasms / Q000188:drug therapy*; D014750:Vincristine / Q000009:adverse effects
chemical_list: D003561:Cytarabine; D001761:Bleomycin; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone; D008727:Methotrexate